Paul Burton

CIK 1869869 · View on SEC EDGAR ↗

Insider

First SEC filing: Nov. 8, 2022 · Latest: Nov. 8, 2022

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 10 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

10 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Nov. 7, 2022 MRNA S 192 $158.68 $30,467 954 Direct -16.75% Disposed -9.7% (price as of 2026-08-20)
Aug. 8, 2022 MRNA S 865 $185.10 $160,112 744 Direct -53.76% Disposed -22.6% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Nov. 4, 2022 MRNA Restricted Stock Units Common Stock (402) $0.00 402 Disposed
Aug. 5, 2022 MRNA Restricted Stock Units Common Stock (1,609) $0.00 1,609 Disposed
June 16, 2022 MRNA Restricted Stock Units Common Stock (10,990) $0.00 10,990 Acquired
June 16, 2022 MRNA Stock Option (Right to Buy) Common Stock (19,772) $121.08 June 16, 2032 19,772 Acquired
June 16, 2022 MRNA Restricted Stock Units Common Stock (3,663) $0.00 3,663 Acquired
June 16, 2022 MRNA Stock Option (Right to Buy) Common Stock (6,902) $121.08 June 16, 2032 6,902 Acquired
March 1, 2022 MRNA Restricted Stock Units Common Stock (1,603) $0.00 1,603 Acquired
March 1, 2022 MRNA Stock Option (Right to Buy) Common Stock (6,505) $149.52 March 1, 2032 6,505 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).